1. Home
  2. BDJ vs TVTX Comparison

BDJ vs TVTX Comparison

Compare BDJ & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDJ
  • TVTX
  • Stock Information
  • Founded
  • BDJ 2005
  • TVTX 2008
  • Country
  • BDJ United States
  • TVTX United States
  • Employees
  • BDJ N/A
  • TVTX N/A
  • Industry
  • BDJ Finance Companies
  • TVTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • BDJ Finance
  • TVTX Health Care
  • Exchange
  • BDJ Nasdaq
  • TVTX Nasdaq
  • Market Cap
  • BDJ 1.5B
  • TVTX 1.4B
  • IPO Year
  • BDJ N/A
  • TVTX N/A
  • Fundamental
  • Price
  • BDJ $8.90
  • TVTX $16.48
  • Analyst Decision
  • BDJ
  • TVTX Strong Buy
  • Analyst Count
  • BDJ 0
  • TVTX 16
  • Target Price
  • BDJ N/A
  • TVTX $33.33
  • AVG Volume (30 Days)
  • BDJ 561.6K
  • TVTX 1.6M
  • Earning Date
  • BDJ 01-01-0001
  • TVTX 07-31-2025
  • Dividend Yield
  • BDJ 8.85%
  • TVTX N/A
  • EPS Growth
  • BDJ N/A
  • TVTX N/A
  • EPS
  • BDJ N/A
  • TVTX N/A
  • Revenue
  • BDJ N/A
  • TVTX $273,533,000.00
  • Revenue This Year
  • BDJ N/A
  • TVTX $73.84
  • Revenue Next Year
  • BDJ N/A
  • TVTX $46.72
  • P/E Ratio
  • BDJ N/A
  • TVTX N/A
  • Revenue Growth
  • BDJ N/A
  • TVTX 75.65
  • 52 Week Low
  • BDJ $6.91
  • TVTX $7.93
  • 52 Week High
  • BDJ $8.66
  • TVTX $25.29
  • Technical
  • Relative Strength Index (RSI)
  • BDJ 60.52
  • TVTX 59.73
  • Support Level
  • BDJ $8.84
  • TVTX $14.44
  • Resistance Level
  • BDJ $8.97
  • TVTX $16.64
  • Average True Range (ATR)
  • BDJ 0.09
  • TVTX 0.61
  • MACD
  • BDJ 0.01
  • TVTX 0.31
  • Stochastic Oscillator
  • BDJ 79.17
  • TVTX 94.18

About BDJ Blackrock Enhanced Equity Dividend Trust

BlackRock Enhanced Equity Dividend Trust is a United States closed-end management investment company. Its investment objective is to seek current income and current gains, with a secondary objective of long-term capital appreciation.

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

Share on Social Networks: